Shares of Pfizer Inc. PFE,
they were down 1.1% and BioNTech SE BNTX,
Shares rose 1.2% in trading Monday after the companies said their COVID-19 vaccine has been recommended for approval in the European Union. The recommendation was made by the Committee for Medicinal Products for Human Use, and it is expected that the European Commission will review and reach a final decision shortly. “If authorized, this is the the first COVID-19 vaccine available in Europe. “Today is particularly personal and emotional for us at BioNTech,” BioNTech President Ugar Sahin said in a statement. “Being at the heart of the EU, we very pleased to be one step closer to delivering the first vaccine in Europe to help fight this pandemic. “BioNTech and Pfizer vaccines received emergency use approval in the US earlier in the year. this month. So far this year, shares of BioNTech have gone up 212.2%, Pfizer stock is up 0.2%, and the S&P 500 SPX,
has received 14.8%.